Stock Quote Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cara Therapeutics (NQ: CARA ) 3.400 +0.120 (+3.66%) Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cara Therapeutics < Previous 1 2 3 4 5 6 7 8 9 Next > Bearish Friday For Marijuana Stocks - Tilray Brands, HEXO Among Top Gainers May 26, 2023 Via Benzinga Cannabis Stock Gainers And Losers From May 25, 2023 May 25, 2023 Via Benzinga Marijuana Stock Movers For May 24, 2023 May 24, 2023 Via Benzinga Cannabis Stock Gainers And Losers From May 18, 2023 May 18, 2023 Via Benzinga Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich… or Broke. May 18, 2023 While lesser-known enterprises present viability risks, those wanting to swing for the fences should seek small-cap stocks to buy. Via InvestorPlace Cara Therapeutics: Q1 Earnings Insights May 15, 2023 Via Benzinga Expert Ratings for Cara Therapeutics April 04, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Friday May 19, 2023 On Friday, 63 companies hit new 52-week lows. Via Benzinga Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus May 18, 2023 Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in... From Cara Therapeutics, Inc. Via GlobeNewswire Bullish Wednesday For Marijuana Stocks - iAnthus Capital Hldgs, Charlottes Web Holdings Among Top Gainers May 17, 2023 Via Benzinga Cannabis Stock Gainers And Losers From May 16, 2023 May 16, 2023 Via Benzinga Cara Therapeutics Revenue Grows 29% To $6.2M May 16, 2023 Cara Therapeutics, Inc. (NASDAQ: CARA) released its financial results for the first quarter ended March 31, 2023, revealing revenues of $6.2 million, an increase of 29% compared to $4.8 million in Q1... Via Benzinga Bullish Sentiment Across The Cannabis Space - Check Full Movers For May 15, 2023 May 15, 2023 Via Benzinga Cara Therapeutics Reports First Quarter 2023 Financial Results May 15, 2023 From Cara Therapeutics, Inc. Via GlobeNewswire Cannabis Stock Movers For May 4, 2023 May 04, 2023 Via Benzinga Marijuana Stock Movers For May 2, 2023 May 02, 2023 Via Benzinga Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023 May 01, 2023 From Cara Therapeutics, Inc. Via GlobeNewswire Cannabis Stock Gainers And Losers From April 28, 2023 April 28, 2023 Via Benzinga Cannabis Stock Movers For April 20, 2023 April 20, 2023 Via Benzinga Cannabis Stock Movers For April 18, 2023 April 18, 2023 Via Benzinga Cannabis Stock Movers For April 17, 2023 April 17, 2023 Via Benzinga Cannabis Stock Movers For April 14, 2023 April 14, 2023 Via Benzinga Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 13, 2023 April 13, 2023 Via Benzinga Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month April 13, 2023 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga Cannabis Stock Gainers And Losers From April 12, 2023 April 12, 2023 Via Benzinga Cannabis Stock Gainers And Losers From April 11, 2023 April 11, 2023 Via Benzinga Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference April 10, 2023 From Cara Therapeutics, Inc. Via GlobeNewswire Marijuana Stock Movers For April 4, 2023 April 04, 2023 Via Benzinga Cannabis Stock Gainers And Losers From March 30, 2023 March 30, 2023 Via Benzinga Cannabis Stock Movers For March 22, 2023 March 22, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
